Oramed Pharmaceuticals Inc. (ORMP) Financials

ORMP Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 316.2 million 41.4 million
March 31, 2026 268.8 million 30.6 million
Dec. 31, 2025 230.9 million 31.1 million
Sept. 30, 2025 220.5 million 18.2 million

ORMP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -202000 1.4 million
March 31, 2026 -2.9 million 1.7 million
Dec. 31, 2025 -264000 2.3 million
Sept. 30, 2025 -2.0 million 719000

ORMP Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 78.2 million
March 31, 2026 38.3 million
Dec. 31, 2025 10.0 million
Sept. 30, 2025 48.4 million

ORMP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 16.1 million 484000 -
March 31, 2026 65.8 million - 493000
Dec. 31, 2025 125.9 million - 540000
Sept. 30, 2025 134.7 million - 589000

ORMP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 42.5 million
March 31, 2026 42.0 million
Dec. 31, 2025 42.4 million
Sept. 30, 2025 42.8 million

ORMP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 2000 - 2.8 million -
March 31, 2026 5000 1.6 million 2.1 million -
Dec. 31, 2025 202000 2.0 million 3.7 million -
Sept. 30, 2025 289 1.2 million 1.3 million -

ORMP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 30000
Dec. 31, 2025 - -61000
Sept. 30, 2025 - 31000

ORMP

Price: $4.68

52 week price:
1.91
5.19

Payout Ratio Range:
0.10%
26.61%

Earnings Per Share: 4.13 USD

P/E Ratio: 1.08

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.6 million

Ebitda: -2.5 million

Market Capitalization: 186.4 million

Years Paying Dividends: 1

Links: